Immunization update: The latest ACIP recommendations
The Journal of Family Practice. 2014 March;63(3):137-140
March 1, 2014|Family Medicine
Author and Disclosure Information
A third meningococcal vaccine broadens coverage for children at high risk of infection. The 13-valent pneumococcal vaccine is now available for use in those 6 to 18 years of age.
As the incidence of antibiotic resistance increases, the primary prevention of bacterial infections becomes more significant. It is of both public health and individual importance that those who develop conditions placing them at increased risk for pneumococcal disease or complications from pneumococcal infection receive recommended pneumococcal vaccines.
